Dunn KJ - Search Results

1

Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.

Kagan RM, Dunn KJ, Snell GP, Nettles RE, Kaufman HW. Kagan RM, et al. Among authors: dunn kj. AIDS Res Hum Retroviruses. 2019 Aug;35(8):698-709. doi: 10.1089/AID.2019.0063. Epub 2019 Jul 10. AIDS Res Hum Retroviruses. 2019. PMID: 31169022

2

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study.

Huhn GD, Crofoot G, Ramgopal M, Gathe J, Bolan R, Luo D, Simonson RB, Nettles RE, Benson C, Dunn K. Huhn GD, et al. Clin Infect Dis. 2020 Dec 15;71(12):3110-3117. doi: 10.1093/cid/ciz1213. Clin Infect Dis. 2020. PMID: 31879782 Free PMC article.

3

Antiretroviral Adherence, Drug Resistance, and the Impact of Social Determinants of Health in HIV-1 Patients in the US.

Benson C, Wang X, Dunn KJ, Li N, Mesana L, Lai J, Wong EY, Chow W, Hardy H, Song J, Brown K. Benson C, et al. Among authors: dunn kj. AIDS Behav. 2020 Dec;24(12):3562-3573. doi: 10.1007/s10461-020-02937-8. AIDS Behav. 2020. PMID: 32488554

4

Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus.

Benson C, Emond B, Romdhani H, Lefebvre P, Côté-Sergent A, Shohoudi A, Tandon N, Chow W, Dunn K. Benson C, et al. J Manag Care Spec Pharm. 2020 Feb;26(2):117-128. doi: 10.18553/jmcp.2019.19174. Epub 2019 Nov 20. J Manag Care Spec Pharm. 2020. PMID: 31747357 Free PMC article.

5

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage.

Benson C, Emond B, Lefebvre P, Lafeuille MH, Côté-Sergent A, Tandon N, Chow W, Dunn K. Benson C, et al. J Manag Care Spec Pharm. 2020 Feb;26(2):129-141. doi: 10.18553/jmcp.2019.19175. Epub 2019 Nov 20. J Manag Care Spec Pharm. 2020. PMID: 31747358 Free PMC article.

6

Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis.

Dunn K, Rogers R, Simonson RB, Luo D, Sheng S, Kassam PT, Seyedkazemi S, Hardy H. Dunn K, et al. HIV Res Clin Pract. 2021 Apr;22(2):55-61. doi: 10.1080/25787489.2021.1915652. Epub 2021 May 17. HIV Res Clin Pract. 2021. PMID: 33999786 Free article.

7

Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks: Post hoc Analyses of AMBER and EMERALD.

Dunn K, Baugh B, Bejou N, Luo D, Campbell J, Seyedkazemi S, Anderson D. Dunn K, et al. J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221088202. doi: 10.1177/23259582221088202. J Int Assoc Provid AIDS Care. 2022. PMID: 35466761 Free PMC article. Clinical Trial.

8

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities: Week 96 subgroup analysis.

Dunn K, Bushen J, Luo D, Cai J, Simonson RB, Anderson D. Dunn K, et al. HIV Med. 2023 Mar;24(3):279-289. doi: 10.1111/hiv.13377. Epub 2022 Aug 15. HIV Med. 2023. PMID: 36912173 Clinical Trial.

9

Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV.

Dunn K, Lafeuille MH, Jiao X, Romdhani H, Emond B, Woodruff K, Pesa J, Tandon N, Lefebvre P. Dunn K, et al. J Manag Care Spec Pharm. 2018 Oct;24(10):1040-1051. doi: 10.18553/jmcp.2018.17507. Epub 2018 Jun 7. J Manag Care Spec Pharm. 2018. PMID: 29877140 Free PMC article.

10

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study.

Emond B, Rossi C, Côté-Sergent A, Dunn K, Lefebvre P, Lafeuille MH, Donga P. Emond B, et al. J Health Econ Outcomes Res. 2021 Jun 14;8(1):88-98. doi: 10.36469/001c.24535. J Health Econ Outcomes Res. 2021. PMID: 34179212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters